Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
01 1METROCHEM API PRIVATE LIMITED
01 1TRELAGLIPTIN SUCCINATE
01 1India
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-072
Start Marketing Date : 2024-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
A Trelagliptin Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trelagliptin Succinate, including repackagers and relabelers. The FDA regulates Trelagliptin Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trelagliptin Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trelagliptin Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trelagliptin Succinate supplier is an individual or a company that provides Trelagliptin Succinate active pharmaceutical ingredient (API) or Trelagliptin Succinate finished formulations upon request. The Trelagliptin Succinate suppliers may include Trelagliptin Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Trelagliptin Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trelagliptin Succinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trelagliptin Succinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trelagliptin Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trelagliptin Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trelagliptin Succinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trelagliptin Succinate suppliers with NDC on PharmaCompass.
We have 1 companies offering Trelagliptin Succinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
